Extendicare Price Target Raised to $13.50 at RBC

MT Newswires Live
03-05

RBC Capital Markets raised its price target on Extendicare Inc. (EXE.TO) to $13.50 from $11.

Analyst Pammi Bir maintained a Sector Perform rating on shares of the Canadian senior care provider.

"Our outlook on EXE continues to improve, with further progress made across segments," Bir said in a note to clients.

"The substantial lift in government funding has stabilized long-term care (LTC), with our forecasts reflecting a return to more typical inflationary-type growth," the analyst said.

"As well, demand at ParaMed is accelerating as it fills the gap created by capacity constraints in LTC and retirement homes," Bir said.

"Together with the benefits of its shift to a capital light model, a clearer and improving picture of growth continues to form."

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10